<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05051839</url>
  </required_header>
  <id_info>
    <org_study_id>14/532</org_study_id>
    <nct_id>NCT05051839</nct_id>
  </id_info>
  <brief_title>Validation Use of Implants and Abutments With Biologically Oriented Preparation Technique</brief_title>
  <official_title>Randomized Clinical Trial to Validate Use of Implants and Abutments With Biologically Oriented Preparation Technique (I.B.O.P.T.)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Complutense de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Complutense de Madrid</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial aims to validate and to establish indications for using&#xD;
      implants with biological oriented preparation technique (I.B.O.P.T.) for implant supported&#xD;
      prosthetic treatment as an option looking for better stability and control of associated soft&#xD;
      and hard tissues compared with conventional implants and conventional abutments with&#xD;
      finishing lines preparation technique.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2017</start_date>
  <completion_date type="Actual">December 15, 2020</completion_date>
  <primary_completion_date type="Actual">June 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Marginal bone level</measure>
    <time_frame>Baseline to 12-months follow-up</time_frame>
    <description>Changes in interproximal marginal bone level with standardization of the radiograph</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Soft tissue volumetric analysis</measure>
    <time_frame>Baseline to 12-motnhs follow-up</time_frame>
    <description>Soft tissue volumetric analysis with digital impressiones taken at baseline and at 12-month follow-up visit</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Dental Implant-Abutment Design</condition>
  <arm_group>
    <arm_group_label>Radiographic bone level</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Peri implant soft tissue volume</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Implant surgery and restoration</intervention_name>
    <description>Implants with two different transmucosal neck configuration are placed.</description>
    <arm_group_label>Peri implant soft tissue volume</arm_group_label>
    <arm_group_label>Radiographic bone level</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female ≥18 years old.&#xD;
&#xD;
          -  Need for implant-supported fixed prosthesis in the posterior area of the upper or&#xD;
             lower jaw (up to 2 implants and three units bridge);&#xD;
&#xD;
          -  Adequate bone quality and quantity at the implant site to allow the insertion of&#xD;
             Sweden and Martina Premium or Prama (Due Carrare, Padova, Italy), of diameters 3.8,&#xD;
             4.25 or 5 mm and lengths between 10 and 13 mm.&#xD;
&#xD;
          -  Healthy ASA type I and II patients.&#xD;
&#xD;
          -  Full-mouth plaque index &lt;20.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers ≥10 cigarettes/day.&#xD;
&#xD;
          -  Presence of implant-supported restorations adjacent to the study site.&#xD;
&#xD;
          -  Active periodontitis defined as the presence of pockets with probing depth (PD) ≥5 mm&#xD;
             and bleeding on probing (BoP).&#xD;
&#xD;
          -  Systemic medication that contraindicates surgery (bisphosphonates or steroid therapy).&#xD;
&#xD;
          -  Uncontrolled diabetes.&#xD;
&#xD;
          -  Severe bruxism.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Previous history of radiotherapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Dentistry, Unviersidad Complutense de Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

